Close
ACHEMA MIDDLE EAST 2026

PeptiDream and Shionogi sign peptide drug conjugate discovery deal

PeptiDream has signed a deal with fellow Japanese pharmaceutical company Shionogi to discover and develop a series of blood-brain barrier (BBB) penetrating peptide drug...

TC BioPharm creates allogeneic cell banks for CAR T cancer therapy products

TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, announced it has completed formulation of its first...

Novartis and University of Oxford to establish AI based Drug Development Alliance

Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics. The partners...

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate a Phase III trial...

Almac Group Extends Personalized Cancer Vaccine Production Facilities

The Almac Group is expanding its Edinburgh Technopole facility to allow scale-up of its personalized cancer vaccine activities. Doubling its footprint in the Fleming...

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of the cutting-edge biological technology and...

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic Steatohepatitis

LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...